FB Pixel no script
MENU
KrASIA

Hong Kong

News

Henlius stands out in Hong Kong’s cooling biotech market with profits and pipeline progress

The firm’s share price has nearly tripled over the past year, driven by steady cash flow, global expansion, and a distinct strategy.

5 mins read
  • The listing, if it moves forward, would test investor appetite for regulated digital asset firms.

    News

    HashKey plans Hong Kong IPO to strengthen lead among licensed crypto exchanges

    5 mins read

Most Recent

See All